Year-end Sale % OFF 
Abstract
To the Editor: During an ongoing analysis of our randomized trial of the use of combined positron-emission tomography and computed tomography (PET–CT) in the preoperative staging of non–small-cell lung cancer (July 2, 2009, issue),1 we discovered an error in the reported data.2 Three patients who were randomly assigned to the PET–CT group and who were initially coded as having undergone PET–CT did not receive this diagnostic test. The primary end point of our study was the number of futile thoracotomies that had been performed, as determined by the intention-to-treat analysis. Thus, the error does not change the published outcome. We . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
